Coya Therapeutics vs HCW Biologics
COYA and HCWB side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How COYA and HCWB compare
Coya Therapeutics is the larger company, worth 48 times as much as HCW Biologics ($70.4M against $1.5M).
HCW Biologics grew revenue faster over the last twelve months (700% versus 17.6% for Coya Therapeutics).
HCW Biologics keeps more of each dollar of sales as profit, with a net margin of −83.8% compared with −643% at Coya Therapeutics.
Coya Therapeutics scores higher on the StockData Score (7 against 6 for HCW Biologics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | COYA | HCWB |
|---|---|---|
| Size and price | ||
| Market cap | $70.4M | $1.5M |
| Share price | $3.00 | $0.800 |
| Change, 1 year | −49.7% | −94.6% |
| Change, 5 years | – | −99.9% |
| Beta (5Y) | 2.14 | 2.44 |
| Employees | 8 | – |
| StockData Score | ||
| Total score | 7 (better) | 6 |
| Valuation score | 1 | 3 (better) |
| Growth score | 1 | 2 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 5 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 15.0× | 0.2× (better) |
| P/B | 2.1× | 0.2× (better) |
| Fair value | $2.58 | $15.29 |
| Margin of safety | −16.2% | 94.8% (better) |
| Growth | ||
| Revenue growth (TTM) | 17.6% | 700% (better) |
| Revenue growth, 5Y average | – | −57.9% |
| Profitability | ||
| Gross margin | – | 96.7% |
| Operating margin | −675% | −115% (better) |
| Net margin | −643% | −83.8% (better) |
| Return on equity | −99.2% (better) | −151% |
| Return on invested capital | – | −70.7% |
| Financial health | ||
| Debt / equity | 0.00 | 0.88 (better) |
| Interest coverage | – | −14.0× |
| Current ratio | 7.24 (better) | 0.06 |
| Altman Z-score | 2.76 (better) | −7.20 |
| Piotroski F-score | 3 (better) | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 33.1% | 5.6% |
| Held by insiders | 5.1% | 34.9% |
| Insider net buying, 12 months | – | $532K |
| Short interest, % of float | 6.3% | 4.1% |
Go deeper
- COYA stock overview
- COYA income statement
- COYA valuation and score
- HCWB stock overview
- HCWB income statement
- HCWB valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.